A NANOG-high/ICAM1-low-expressing population existed in a clinical sample of PCa tumors (Additional file 1: Figure S7), and the levels of ICAM1 expression between localized PCa and castration-resistant PCa (CRPC) were compared based on The Cancer Genome Atlas (TCGA) microarray data. This evidence concerns the gene NANOG and posterior cortical atrophy.